×
Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.
Arnon TI., Markel G., Bar-Ilan A., Hanna J., Fima E., Benchetrit F., Galili R., Cerwenka A., Benharroch D., Sion-Vardy N., Porgador A., Mandelboim O.
DOI
10.1371/journal.pone.0128052
Type
Journal article
Journal
PLoS One
Publication Date
2015
Volume
10